Bellerophon Therapeutics, Inc. (BLPH)
OTCMKTS: BLPH · Delayed Price · USD
0.0560
0.00 (0.00%)
May 7, 2024, 11:01 AM EDT - Market open

Bellerophon Therapeutics Market Cap

Bellerophon Therapeutics has a market cap or net worth of $685.03 thousand as of May 8, 2024. Its market cap has decreased by -93.48% in one year.

Market Cap
685.03K
Enterprise Value
-3.70M
1-Year Change
-93.48%
Ranking
n/a
Category
Stock Price
$0.06

Market Cap Chart

Since February 13, 2015, Bellerophon Therapeutics's market cap has decreased from $106.80M to $685.03K, a decrease of -99.36%. That is a compound annual growth rate of -44.15%.

History

DateMarket Cap% Change
Oct 13, 20231.20M-74.47%
Oct 12, 20234.70M2.17%
Oct 11, 20234.60M2.22%
Oct 10, 20234.50M-2.17%
Oct 9, 20234.60M-
Oct 6, 20234.60M4.55%
Oct 5, 20234.40M-2.22%
Oct 4, 20234.50M-4.26%
Oct 3, 20234.70M-2.08%
Oct 2, 20234.80M-2.04%
Sep 29, 20234.90M4.26%
Sep 28, 20234.70M2.17%
Sep 27, 20234.60M-6.12%
Sep 26, 20234.90M-
Sep 25, 20234.90M-2.00%
Sep 22, 20235.00M-
Sep 21, 20235.00M-7.41%
Sep 20, 20235.40M14.89%
Sep 19, 20234.70M-6.00%
Sep 18, 20235.00M-1.96%
Sep 15, 20235.10M-7.27%
Sep 14, 20235.50M-
Sep 13, 20235.50M1.85%
Sep 12, 20235.40M-
Sep 11, 20235.40M1.89%
View and export this data all the way back to 2015. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly 739.20B
Novo Nordisk 542.69B
UnitedHealth Group 460.92B
Johnson & Johnson 357.92B
Merck & Co. 330.23B
AbbVie 287.04B
AstraZeneca 236.58B
Thermo Fisher 218.67B
Market Cap Rankings